EL

Estée Lauder Companies

$86.56

+2.27%
Jun 9, 2026
Bobby Quantitative Model
The Estée Lauder Companies Inc. is a global leader in the prestige beauty market, operating across key categories including skin care (49% of fiscal 2025 sales), makeup, fragrance, and hair care through a portfolio of iconic brands such as Estée Lauder, Clinique, M.A.C, and La Mer. The company is a dominant market player with a powerful multi-brand, multi-channel distribution model spanning department stores, travel retail, e-commerce, and freestanding stores across more than 150 countries. The current investor narrative is dominated by the company's ongoing turnaround story, as it navigates a challenging post-pandemic recovery in key Asian travel retail channels while executing a strategic restructuring plan to restore profitability, a focus underscored by recent news of the company walking away from merger talks to pursue its independent path.

People also watch

Procter & Gamble

Procter & Gamble

PG

Analysis
Colgate-Palmolive Company

Colgate-Palmolive Company

CL

Analysis
Kenvue

Kenvue

KVUE

Analysis
Kimberly-Clark

Kimberly-Clark

KMB

Analysis
Church & Dwight

Church & Dwight

CHD

Analysis

BobbyInvestment Opinion: Should I buy EL Today?

Rating: Hold. The core thesis is that EL presents a high-risk, high-reward turnaround bet where the deep valuation discount is justified by real and persistent operational challenges, making it suitable only for risk-tolerant investors with a long time horizon.

Supporting this view, the stock trades at a depressed PS ratio of 2.04 versus typical industry multiples of 3x-4x, signaling substantial pessimism. While Q2 revenue grew 5.84% YoY, profitability remains weak with a 6.70% operating margin. The high debt-to-equity of 2.44 is a major overhang, though it is partially offset by strong TTM free cash flow of $1.14 billion. Analyst sentiment is mixed but leans cautiously constructive, with an average EPS estimate of $5.76 for the upcoming period.

The thesis would upgrade to a Buy if the company demonstrates two consecutive quarters of sustained revenue growth above 5% and expands operating margins above 10%, confirming the restructuring is working. It would downgrade to a Sell if revenue growth turns negative or if net debt increases significantly, jeopardizing financial stability. Currently, the stock is fairly valued relative to its challenged near-term prospects but deeply undervalued relative to its long-term brand potential, placing it in a 'show me' state.

Sign up to view all

EL 12-Month Price Forecast

The outlook for EL is a balanced but tense waiting game. The base case (55% probability) of a slow, grinding recovery is most likely, anchored by the company's strong brands and cash flow, but heavily constrained by its leverage and the need to prove its restructuring plan. The bull case offers compelling upside if execution is flawless, but the bear case risk of a failed turnaround and balance sheet stress is material. The stance would upgrade to bullish on evidence of sustained margin expansion and debt reduction, or downgrade to bearish on a breakdown in revenue trends or a liquidity scare.

Historical Price
Current Price $86.56
Average Target $95
High Target $135
Low Target $60

Wall Street consensus

Most Wall Street analysts maintain a constructive view on Estée Lauder Companies's 12-month outlook, with a consensus price target around $112.53 and implied upside of +30.0% versus the current price.

Average Target

$112.53

8 analysts

Implied Upside

+30.0%

vs. current price

Analyst Count

8

covering this stock

Price Range

$69 - $113

Analyst target range

Buy
2 (25%)
Hold
4 (50%)
Sell
2 (25%)

Analyst coverage for Estée Lauder is limited in the provided data, with only 8 analysts providing estimates for future EPS and revenue, indicating a narrower but likely still institutional following. The consensus sentiment appears mixed but leans cautiously constructive, as evidenced by recent actions from major firms: Citigroup upgraded the stock from Neutral to Buy in early February 2026, while Deutsche Bank and JP Morgan maintain Buy/Overweight ratings, and Wells Fargo and TD Cowen hold Equal Weight/Hold stances. The average revenue estimate for the upcoming period is approximately $17.99 billion, with a tight range between $17.62 billion and $18.21 billion, suggesting analysts have clustered expectations. The average EPS estimate is $5.76, with a low of $5.60 and a high of $5.85. The relatively tight range between the low and high EPS estimates signals a degree of consensus on the near-term earnings trajectory, though the wide dispersion in price targets (not explicitly provided but implied by varied ratings) reflects ongoing debate about the valuation appropriate for the company's recovery story.

Drowning in data?

Find the real signal!

Bulls vs Bears: EL Investment Factors

The investment debate for Estée Lauder centers on a classic turnaround story: deep valuation discount and strong brand fundamentals versus severe profitability pressure and high financial leverage. Currently, the bear side holds stronger evidence, as the stock's persistent downtrend, negative trailing profitability, and high debt are concrete, present-tense risks. The most important tension is the timing and efficacy of the restructuring plan. If management can demonstrably restore consistent revenue growth and expand operating margins from the current 6.7%, the deeply discounted sales multiple offers substantial upside. Conversely, if profitability remains elusive or debt becomes burdensome, the stock could retest its 52-week low.

Bullish

  • Deeply Discounted Valuation: EL trades at a trailing PS ratio of 2.04 and EV/Sales of 2.42, a significant discount to the typical 3x-4x range for prestige consumer goods and near the bottom of its own historical range (e.g., PS was 8.95 in Q2 FY2026). This compression prices in extreme pessimism, offering substantial upside if the turnaround succeeds.
  • Strong Free Cash Flow Generation: Despite profitability challenges, the company generated $1.14 billion in trailing twelve-month free cash flow. This provides crucial internal resources to fund its strategic restructuring, service its debt, and navigate the recovery without needing to raise dilutive capital.
  • Positive Revenue Inflection: Q2 FY2026 revenue grew 5.84% YoY to $4.24 billion, a notable improvement from prior quarters. This suggests the post-pandemic recovery, particularly in key Asian travel retail, may be gaining traction, providing a fundamental basis for the turnaround narrative.
  • Robust Gross Margin Profile: The company maintains a strong gross margin of 73.89% (76.55% in the latest quarter), underscoring the pricing power and brand equity of its prestige portfolio. This provides a solid foundation for operating leverage once restructuring costs abate and sales stabilize.

Bearish

  • Severe Profitability Pressure: The company's trailing net margin is -7.93%, and it posted a net loss of -$546 million in Q4 FY2025. While Q2 FY2026 showed a $162 million profit, the operating margin is thin at 6.70%, indicating significant SG&A cost challenges that the restructuring must urgently address.
  • High Financial Leverage: EL carries a debt-to-equity ratio of 2.44, indicating substantial financial leverage. This high debt burden increases interest expense risk and limits financial flexibility, making the company more vulnerable to prolonged operational underperformance or rising rates.
  • Persistent Technical Downtrend: The stock is down 21.15% over six months and 22.35% YTD, significantly underperforming the SPY. With a beta of 1.21, it exhibits amplified volatility, and its current price of $82.90 is 31.9% below its 52-week high, reflecting sustained selling pressure and weak momentum.
  • Inconsistent Recovery Trajectory: Revenue over recent quarters has been volatile ($3.41B, $3.55B, $3.48B, $4.24B), indicating the nascent recovery is not yet consistent. This instability raises doubts about the sustainability of growth, especially in the critical but challenged travel retail channel.

EL Technical Analysis

The stock is in a pronounced downtrend, having declined 21.15% over the last six months and 22.35% year-to-date as of the analysis date, significantly underperforming the broader market. With a current price of $82.90, the stock is trading approximately 31.9% above its 52-week low of $66.22 but remains 31.9% below its 52-week high of $121.64, positioning it in the lower-middle of its annual range and suggesting it is in a deep correction phase rather than presenting a clear value opportunity. Recent momentum shows a stark divergence, with the stock up 6.04% over the past month, potentially signaling a short-term relief rally or stabilization attempt, yet this is overshadowed by a 10.59% decline over the prior three months, indicating that any recent positive momentum is fragile and occurring within a larger bearish context. Key technical support is firmly established at the 52-week low of $66.22, while resistance sits at the 52-week high of $121.64; a sustained break below support could trigger a new leg down, whereas reclaiming the $100 level would be a first step toward challenging the downtrend. The stock's beta of 1.211 indicates it is approximately 21% more volatile than the SPY, which is notable given its defensive sector, implying amplified moves on market sentiment and contributing to its significant 43.79% maximum drawdown.

Beta

1.25

1.25x market volatility

Max Drawdown

-43.8%

Largest decline past year

52-Week Range

$66-$122

Price range past year

Annual Return

+25.4%

Cumulative gain past year

PeriodEL ReturnS&P 500
1m+0.4%-0.1%
3m-5.4%+9.0%
6m-18.0%+7.0%
1y+25.4%+22.9%
ytd-18.9%+8.1%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

EL Fundamental Analysis

Revenue growth has been volatile but showed a positive inflection in the most recent quarter (Q2 FY2026 ending Dec 31, 2025), with revenue of $4.24 billion representing a 5.84% year-over-year increase, a notable improvement from the prior quarter's revenue of $3.48 billion. However, the multi-quarter trend reveals instability, with revenues of $3.41 billion and $3.55 billion in the quarters preceding that, indicating the recovery is nascent and not yet consistent. The company's profitability is under severe pressure, as evidenced by a trailing twelve-month net margin of -7.93% and a quarterly net income of $162 million in Q2 FY2026, which, while positive, follows a significant net loss of -$546 million in the prior quarter (Q4 FY2025); the gross margin remains robust at 73.89%, but operating margin is thin at 6.70%, highlighting significant SG&A cost challenges. The balance sheet and cash flow present a mixed picture: the company carries a high debt-to-equity ratio of 2.44, indicating substantial financial leverage, but it maintains a reasonable current ratio of 1.30 for liquidity. Crucially, the company generated $1.14 billion in trailing twelve-month free cash flow, providing internal resources to fund its restructuring and navigate the turnaround, though the high debt load remains a key risk factor for investors.

Quarterly Revenue

$4.2B

2025-12

Revenue YoY Growth

+0.05%

YoY Comparison

Gross Margin

+0.76%

Latest Quarter

Free Cash Flow

$1.1B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Fragrance
Hair Care
Makeup
Skin Care

Open an Account, get $2 TSLA now!

Valuation Analysis: Is EL Overvalued?

Given the company's negative trailing net income, the primary valuation metric selected is the Price-to-Sales (PS) ratio. Estée Lauder trades at a trailing PS ratio of 2.04 and an EV/Sales of 2.42, which are depressed multiples reflecting its operational challenges. Compared to typical industry averages for prestige consumer goods (often in the 3x-4x sales range), EL trades at a significant discount, though this is warranted given its profitability struggles and elevated debt. Historically, the stock's own valuation has compressed dramatically; for instance, its PS ratio was as high as 8.95 in Q2 FY2026 and 19.50 in mid-2021. The current PS of 2.04 sits near the bottom of its multi-year historical range, suggesting the market is pricing in substantial pessimism regarding the turnaround's success or future growth prospects, presenting a potential value opportunity if fundamentals stabilize.

PE

-25.7x

Latest Quarter

vs. Historical

Mid-Range

5-Year PE Range -533x~438x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

184.5x

Enterprise Value Multiple

Investment Risk Disclosure

Financial & Operational Risks are pronounced. The company's high debt-to-equity ratio of 2.44 creates a significant interest burden and reduces financial flexibility. Profitability is severely pressured, with a trailing net margin of -7.93% and volatile quarterly results, including a -$546 million net loss in Q4 FY2025. While free cash flow of $1.14 billion provides a buffer, the company remains dependent on a successful and timely execution of its restructuring plan to restore consistent earnings, without which its leveraged balance sheet becomes a major vulnerability.

Market & Competitive Risks include valuation compression and sector-specific headwinds. With a forward P/E of 26.1, EL trades at a premium that demands flawless execution of its turnaround. The stock's beta of 1.211 makes it 21% more volatile than the market, amplifying downside moves during risk-off periods. Competitively, the prestige beauty space is intense, and EL's heavy reliance on travel retail (a key part of its EMEA segment) exposes it to geopolitical tensions and shifts in consumer travel patterns that could delay recovery further.

Worst-Case Scenario involves a failure of the restructuring plan to gain traction, leading to consecutive earnings misses, a credit rating downgrade due to its high leverage, and a loss of investor confidence in the independent turnaround story. This could trigger a wave of analyst downgrades and force the company to raise equity at deeply discounted prices. Realistic downside could see the stock retesting and breaking below its 52-week low of $66.22, representing a potential loss of approximately -20% from the current price of $82.90, with further declines possible if negative momentum accelerates.

FAQ

The key risks are, in order of severity: 1) Financial Risk: High debt-to-equity of 2.44 limits flexibility and increases vulnerability to interest rate hikes or earnings shortfalls. 2) Operational Risk: The trailing net margin of -7.93% indicates the restructuring plan must work to restore profitability; failure would crush the investment thesis. 3) Market Risk: The stock's beta of 1.211 leads to amplified volatility, and its 43.79% max drawdown shows it can suffer severe declines. 4) Execution Risk: The company's recovery is nascent and inconsistent; a stumble in key markets like Asian travel retail could delay the turnaround indefinitely.

The 12-month forecast is bifurcated, with a base case target range of $85-$105 (55% probability), a bull case of $115-$135 (25%), and a bear case of $60-$75 (20%). The base case assumes slow but steady progress on the turnaround, with revenue growth stabilizing and margins improving gradually. The bull case requires flawless execution and a sharp rebound in profitability, while the bear case involves a failed restructuring and balance sheet stress. The most likely outcome is the base case, but the wide range reflects the high uncertainty surrounding the company's ability to execute its independent plan successfully.

EL's valuation presents a paradox. On a sales basis, it appears deeply undervalued, with a trailing PS ratio of 2.04 and EV/Sales of 2.42, well below typical industry multiples of 3x-4x and its own historical highs above 8x. This suggests the market is pricing in substantial distress. However, on an earnings basis, the forward P/E of 26.1 is high, implying the market expects a rapid profit recovery. Overall, the stock is fairly valued relative to its near-term challenged fundamentals but undervalued relative to its long-term brand asset value, making the valuation highly dependent on the success of the ongoing turnaround.

EL is a speculative buy, suitable only for investors with a high risk tolerance and a long-term horizon. The stock offers a compelling valuation opportunity, trading at a PS ratio of 2.04, a deep discount to its historical range and industry peers. However, this discount is warranted by severe profitability challenges (trailing net margin of -7.93%) and high financial leverage (debt-to-equity of 2.44). The potential upside is significant if the restructuring succeeds, but the downside risk to the 52-week low of $66.22 is real. It is a good buy for turnaround investors, but not for those seeking stability or income.

EL is strictly a long-term investment with a suggested minimum holding period of 3-5 years. The company is in the midst of a multi-year restructuring; tangible proof of a sustained turnaround will take several quarters, if not years, to materialize. The stock's high beta of 1.211 and lack of a meaningful dividend (yield of 2.1%) make it unsuitable for short-term trading or income-seeking investors. It is a capital appreciation story for patient investors willing to bet on management's ability to fix the operations and de-lever the balance sheet over the long haul.